Atherosclerosis is the major process underlying cardiovascular disorders, and accounts for the majority of mortality and morbidity in the western world. This course will give more insights into the mechanism and ontogenesis of vessel narrowing (atherosclerosis). Special emphasis will be put on the contribution of inflammatory processes and lipid fluxes in the development of atherosclerotic lesions. Also the clinical end-points of atherosclerosis will be discussed.
The following subjects will be discussed:
Cholesterol metabolism and atherosclerotic lesion formation
Role of macrophages in atherosclerotic lesion formation
Role of inflammation in atherosclerotic lesion formation and progression
Therapeutic approaches for the stabilization of vulnerable atherosclerotic plaques
Coordinator
Mw. dr. Miranda van Eck
Students
Students of Bio-Pharmaceutical Sciences.
Method of instruction
Lectures.
Required reading
Will be announced during the lectures.
Examination
Written exam.
minimal amount of students
Minimum of 5 students
Time table
Dates and times of the caput lecture series Biopharmaceutics (Atherosclerosis) for the Academic Year 2008—2009 are as follows:
*Tuesday, May 18, 09.00—12.45 h *Wednesday, May 19, 09.00—12.45 h *Thursday, May 20, 09.00—12.45 h *Monday, May 25, 09.00—12.45 h *Tuesday, May 26, 09.00—12.45 h
See the schedule of the lecture series in the master study guide 2008—2009.
*Examination: Friday, May 29, 10.00—13.00 h.
Application
For information, please contact mw. dr. Miranda van Eck (e-mail: m.eck@lacdr.leidenuniv.nl, tel. 527 6238).
Applications for the course can be send to the secretarial office of the Division of Biopharmaceutics (Bart Verschoor; e-mail: verschoorbj@lacdr.leidenuniv.nl).